Literature DB >> 3135883

Abnormal flow properties of white blood cells in patients with severe ischaemia of the leg.

G B Nash1, P R Thomas, J A Dormandy.   

Abstract

The possible role of white blood cells in tissue ischaemia has attracted recent interest. White blood cells can block narrow vessels, particularly if perfusion pressure is reduced or if the cells become activated. To investigate the role of white blood cells in ischaemia microfiltration techniques were used to measure the flow properties of these cells in patients with severe leg ischaemia before and after amputation. Compared with controls white blood cells from patients showed impaired ability to flow through 8 micron and 5 micron pore filters. This applied to fractionated granulocytes and mononuclear cells as well as to unfractionated mixed white blood cells. White blood cells from blood draining the ischaemic leg had worse filterability than those from arm blood of the same patients. After amputation of the ischaemic leg there was definite improvement, the flow properties of the cells being no longer significantly different from controls. These abnormalities detected in white blood cells probably reflect activation of the cells by factors released in the ischaemic tissue. As activation alters the mechanical and adhesive properties of white blood cells, a vicious cycle of microcirculatory trapping at low perfusion pressure, activation, tissue damage, and further activation and trapping might contribute to the progressive worsening of tissue ischaemia.

Entities:  

Mesh:

Year:  1988        PMID: 3135883      PMCID: PMC2546089          DOI: 10.1136/bmj.296.6638.1699

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  10 in total

1.  Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia.

Authors:  R L Engler; M D Dahlgren; M A Peterson; A Dobbs; G W Schmid-Schönbein
Journal:  Am J Physiol       Date:  1986-07

2.  Leukocyte effects on the vascular resistance and glomerular filtration of the isolated rat kidney at normal and low flow states.

Authors:  M Braide; A Blixt; U Bagge
Journal:  Circ Shock       Date:  1986

Review 3.  Leukocytes and ischemia-induced myocardial injury.

Authors:  B R Lucchesi; K M Mullane
Journal:  Annu Rev Pharmacol Toxicol       Date:  1986       Impact factor: 13.820

Review 4.  Interactions between neutrophils and microvascular endothelial cells leading to cell emigration and plasma protein leakage.

Authors:  T J Williams; P J Jose; M J Forrest; C V Wedmore; G F Clough
Journal:  Kroc Found Ser       Date:  1984

5.  Quantitative studies on the influence of leukocytes on the vascular resistance in a skeletal muscle preparation.

Authors:  M Braide; B Amundson; S Chien; U Bagge
Journal:  Microvasc Res       Date:  1984-05       Impact factor: 3.514

Review 6.  Leukocyte-endothelial interactions.

Authors:  J M Harlan
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

Review 7.  Leukocytes and the risk of ischemic diseases.

Authors:  E Ernst; D E Hammerschmidt; U Bagge; A Matrai; J A Dormandy
Journal:  JAMA       Date:  1987-05-01       Impact factor: 56.272

8.  The ischaemic leg as a source of complement activation.

Authors:  A Bengtson; P Holmberg; M Heideman
Journal:  Br J Surg       Date:  1987-08       Impact factor: 6.939

9.  Pulmonary leukosequestration induced by hind limb ischemia.

Authors:  H Anner; R P Kaufman; L Kobzik; C R Valeri; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1987-08       Impact factor: 12.969

10.  Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog.

Authors:  R L Engler; G W Schmid-Schönbein; R S Pavelec
Journal:  Am J Pathol       Date:  1983-04       Impact factor: 4.307

  10 in total
  9 in total

1.  Do leukocytes have a role in the cerebral no-reflow phenomenon?

Authors:  M Mercuri; G Ciuffetti; R Lombardini; C Neri; M Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

2.  Haemorheological treatment of ischaemia--facts or fancy?

Authors:  D Shields; S Sarin
Journal:  J R Soc Med       Date:  1992-06       Impact factor: 5.344

3.  Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study.

Authors:  G Ciuffetti; M Mercuri; C Ott; R Lombardini; R Paltriccia; G Lupattelli; L Santambrogio; E Mannarino
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Argatroban increases nitric oxide levels in patients with peripheral arterial obstructive disease: placebo-controlled study.

Authors:  Y Ueki; K Matsumoto; Y Kizaki; K Yoshida; Y Matsunaga; M Yano; S Miyake; Y Tominaga; K Eguchi
Journal:  J Thromb Thrombolysis       Date:  1999-08       Impact factor: 2.300

5.  Changes in the flow properties of white blood cells after acute myocardial infarction.

Authors:  G B Nash; B Christopher; A J Morris; J A Dormandy
Journal:  Br Heart J       Date:  1989-11

6.  Effect of ingested pentoxifylline on neutrophil superoxide anion production.

Authors:  S P Crouch; J Fletcher
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 7.  Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders.

Authors:  J E Frampton; R N Brogden
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

Review 8.  The microvascular pathophysiology of chronic venous insufficiency.

Authors:  P F McDonagh
Journal:  Yale J Biol Med       Date:  1993 Jan-Feb

9.  A role for the endothelial glycosaminoglycan hyaluronan in neutrophil recruitment by endothelial cells cultured for prolonged periods.

Authors:  Lynn M Butler; G Ed Rainger; Gerard B Nash
Journal:  Exp Cell Res       Date:  2009-08-28       Impact factor: 3.905

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.